is Perindoprilat optional? [Regulatives / Guidelines]

posted by mittyri – Russia, 2018-05-17 22:47 (895 d 16:29 ago) – Posting: # 18779
Views: 2,671

Dear All,

could you please enlighten me what is the reason to analyse and describe PK of Perindoprilat when one of APIs is Perindopril (as an example)?
As EMA stated
Also for inactive prodrugs, demonstration of bioequivalence for parent compound is recommended.
The active metabolite does not need to be measured.


What is the reason why the experts could insist to include Perindoprilat to the list of analytes?

Kind regards,
Mittyri

Complete thread:

Activity
 Admin contact
21,179 posts in 4,414 threads, 1,477 registered users;
online 5 (0 registered, 5 guests [including 3 identified bots]).
Forum time: Thursday 14:17 CET (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5